Financial Data and Key Metrics Changes - The company reported $2.2 billion in revenue for Q1 2025, growing 1% on a reported basis and 9% on an organic operational basis, driven by 4% price and 5% volume growth [22][19] - Adjusted net income was $662 million, growing 4% on a reported basis and 6% on an organic operational basis [22][19] - Adjusted gross margin increased to 72.1%, growing 140 basis points on a reported basis [33] Business Line Data and Key Metrics Changes - The companion animal portfolio generated $1.5 billion in revenue, growing 9% operationally [22] - The Simparica franchise contributed $367 million, growing 19%, while key dermatology posted $387 million, growing 10% [22] - Livestock revenue declined 2% on an organic operational basis, primarily due to aggressive price competition [28] Market Data and Key Metrics Changes - The U.S. segment grew 2% on a reported basis and 6% on an organic operational basis, with companion animal growing 8% and livestock declining 2% [24] - International revenue was flat on a reported basis but grew 11% on an organic operational basis, with companion animal growing 10% and livestock growing 12% [28] Company Strategy and Development Direction - The company is focused on executing its strategy with discipline, supported by a strong balance sheet and operational excellence [9] - The company aims to maintain its full-year organic operational revenue guidance range of 6% to 8% [19] - The company is investing in medical education and direct-to-consumer campaigns to drive awareness and adoption of its products [16][62] Management's Comments on Operating Environment and Future Outlook - Management expressed confidence in the resilience of the animal health industry despite macroeconomic uncertainties [19] - The company is maintaining its full-year adjusted net income guidance of $2.775 billion to $2.825 billion, reflecting operational growth of 5% to 7% [38] - Management highlighted the importance of innovation and customer engagement in navigating the current environment [20] Other Important Information - The company received conditional licensure from the USDA for an avian influenza vaccine for chickens [17] - The company is actively monitoring the impact of tariffs and has reflected the net impact of current tariffs in its guidance [46][73] Q&A Session Summary Question: What is the response to the Librela label change and the tariff impacts? - Management reported a 15% organic operating growth in Librela globally, with strong vet satisfaction and ongoing education efforts [42][44] - The tariff impact embedded in guidance primarily relates to imports from China and is expected to be around $20 million [46][73] Question: What competitive pressures are being faced in the market? - Management acknowledged competitive entrants but emphasized the company's first-mover advantage and continued growth in key franchises [51][54] Question: How is the company addressing consumer sentiment and compliance? - Management noted a more measured approach to managing chronic conditions but remains confident in the durability of the animal health industry [94] Question: What are the expectations for price and volume for the rest of the year? - The company expects price to be above historical levels but below those of the previous years, with volume growth remaining strong [97]

Xometry (XMTR) Q1 2025 Earnings Call May 06, 2025 08:30 AM ET Speaker0 Good day, and thank you for standing by. Welcome to the Xometry q one twenty twenty five earnings call. At this time, all participants are in a listen only mode. After the presentation, there will be a question and answer session. To ask a question during the session, you will need to press 11 on your telephone. You'll then hear an automated message advising that your hand is raised. Please limit yourself to one question per person. Plea ...

Vivid Seats (SEAT) Q1 2025 Earnings Call May 06, 2025 08:30 AM ET Speaker0 Good morning, and welcome to the Vivid Seats First Quarter twenty twenty five Earnings Conference Call. Following the management's prepared remarks, we will open the call for Q and A. I would now like to turn the call over to Emily Epstein. Speaker1 Good morning, and welcome to Vivid Seats' First Quarter twenty twenty five Earnings Conference Call. I'm Emily Epstein, General Counsel at Vivid Seats. Joining me today to discuss Vivid S ...

Uniti Group (UNIT) Q1 2025 Earnings Call May 06, 2025 08:30 AM ET Speaker0 Good morning. Thank I'm to discuss Unity's First Quarter twenty twenty and I'll be your operator for today. Today's call is being recorded and a webcast will be available on the company's Investor Relations website, investor.unity.com, beginning today and will remain available for three sixty five days. It is now my pleasure to introduce Bill DeTullio, Unity's Senior Vice President of Investor Relations and Treasury. Please begin. Sp ...

UL Solutions (ULS) Q1 2025 Earnings Call May 06, 2025 08:30 AM ET Company Participants Mitchell Ji - Senior Vice President of Corporate FinanceJennifer Scanlon - President & CEORyan Robinson - Executive VP & CFOStephanie Moore - SVP - Equity ResearchArthur Truslove - Director Conference Call Participants George Tong - Sr. Research Analyst - Equity ResearchJosh Chan - Executive Director - Equity Research AnalystJun-Yi Xie - Equity Research AnalystAndrew Nicholas - Equity Research AnalystBrett Castelli - Anal ...

UL Solutions (ULS) Q1 2025 Earnings Call May 06, 2025 08:30 AM ET Speaker0 Good day, and welcome to the UL Solutions First Quarter twenty twenty five Earnings Conference Call. All participants will be in a listen only mode. After today's presentation, there will be an opportunity to ask questions. Please note this event is being recorded. I would now like to turn the call over to your host Mr. Mitchell G, Senior Vice President of Corporate Finance at UL Solutions. Thank you. You may now begin. Speaker1 Than ...

TreeHouse Foods (THS) Q1 2025 Earnings Call May 06, 2025 08:30 AM ET Speaker0 Welcome to the TreeHouse Foods First Quarter twenty twenty five Conference Call. All participants are in a listen only mode. After today's presentation, there will be an opportunity to ask questions. Please note this call is being recorded. At this time, I would like to turn the call over to TreeHouse Foods for the reading of the Safe Harbor statement. Speaker1 Good morning and thank you for joining us today. Earlier this morning, ...

Talkspace (TALK) Q1 2025 Earnings Call May 06, 2025 08:30 AM ET Speaker0 Good morning, ladies and gentlemen, and thank you for standing by. My name is Kelvin, and I will be your conference operator today. At this time, I would like to welcome everyone to the Talk Space First Quarter twenty twenty five Earnings Call. All lines have been placed on mute to prevent any background noise. After the speakers' remarks, there will be a question and answer question Thank you. I would now like to turn the call over to ...

SiriusPoint (SPNT) Q1 2025 Earnings Call May 06, 2025 08:30 AM ET Company Participants Liam Blackledge - Investor Relations and Strategy ManagerScott Egan - CEOJim McKinney - CFO Operator Good morning, ladies and gentlemen, and welcome to Series Point's First Quarter twenty twenty five Earnings Conference Call. During today's presentation, all parties will be in a listen only mode. As a reminder, this conference call is being recorded and a replay is available through 11:59 p. M. Eastern Time on 05/20/2025. ...

SiriusPoint (SPNT) Q1 2025 Earnings Call May 06, 2025 08:30 AM ET Speaker0 Good morning, ladies and gentlemen, and welcome to Series Point's First Quarter twenty twenty five Earnings Conference Call. During today's presentation, all parties will be in a listen only mode. As a reminder, this conference call is being recorded and a replay is available through 11:59 p. M. Eastern Time on 05/20/2025. With that, I would like to turn the call over to Liam Blackledge, Investor Relations and Strategy Manager. Pleas ...